Alkermes Revenue and Competitors
Estimated Revenue & Valuation
- Alkermes's estimated annual revenue is currently $1.1B per year.
- Alkermes's estimated revenue per employee is $397,747
- Alkermes's total funding is $250M.
Employee Data
- Alkermes has 2841 Employees.
- Alkermes grew their employee count by -3% last year.
Alkermes's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP | Reveal Email/Phone |
2 | VP Sales, Addiction Division | Reveal Email/Phone |
3 | SVP Quality | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | SVP IT/CIO | Reveal Email/Phone |
6 | SVP, Corporate Counsel | Reveal Email/Phone |
7 | VP, Marketing | Reveal Email/Phone |
8 | VP, Head Molecular Discovery | Reveal Email/Phone |
9 | VP, Pharmaceutical Development | Reveal Email/Phone |
10 | VP External Operations and Supply Chain | Reveal Email/Phone |
Alkermes Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Alkermes?
Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. It has several areas of focus, including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks, using its ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on its proprietary AIR(TM) pulmonary technology. In addition to its Cambridge, Massachusetts, headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England.
keywords:Biotechnology
$250M
Total Funding
2841
Number of Employees
$1.1B
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alkermes News
Alkermes, which develops drugs in the neuroscience and oncology fields, said it triggered the dispute resolution clause of the agreements after...
DUBLIN, April 20, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET...
Under these agreements, Janssen received access and rights to Alkermes' small particle pharmaceutical compound technology, known as NanoCrystal®...
Rodin Therapeutics, a Cambridge, MA-based biotechnology company discovering and developing novel therapeutics to boost synaptic resilience, completed a $27m financing round. The round included returning investor Atlas Venture, with further participation from GV, Hatteras Venture Partners, Remed ...
Rodin Therapeutics, a Cambridge, MA-based biotechnology company applying insights from epigenetics to develop novel therapeutics for neurological disorders, raised $17.3m in funding. Backers included Atlas Venture and Biogen. In addition to this financing, Rodin and Biogen have entered into a m ...
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1149.1M | 3350 | 4% | N/A |
#2 | $672M | 3615 | 6% | $111.9M |
#3 | $829.3M | 4085 | N/A | N/A |
#4 | $664.6M | 4193 | 6% | $7M |
#5 | $666.2M | 4665 | 10% | N/A |